Neil Gallagher
President chez SYNDAX PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Neil Gallagher is currently the Director at Zymeworks, Inc. since 2024 and the President, Head-Research & Development at Syndax Pharmaceuticals, Inc. since 2023.
Previously, he worked at AbbVie, Inc. as the Chief Medical Officer & Head-Development.
Dr. Gallagher holds a doctorate degree from the University of Birmingham and an undergraduate degree from Trinity College, Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/03/2024 | 47 813 ( 0,06% ) | 1 M $ | 31/03/2024 |
Postes actifs de Neil Gallagher
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | President | 10/04/2023 |
| ZYMEWORKS INC. | Director/Board Member | 02/04/2024 |
Anciens postes connus de Neil Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | President | - |
Formation de Neil Gallagher
| University of Birmingham | Doctorate Degree |
| Trinity College, Cambridge | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| ZYMEWORKS INC. | Health Technology |
